Mind-blowing applications of QSP in drug development: Part 2
Part 2 of this blog series dives further into the June 2022 podcast with R&D…
CertaraAugust 15, 2022
Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development?
Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…
CertaraAugust 5, 2022
Mind-blowing applications of QSP in drug development: Part 1
R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…
CertaraAugust 4, 2022
Simcyp® Discovery Simulator
Tailored for discovery and translational scientists, Simcyp® Discovery Simulator is an intuitive software that delivers…
CertaraJuly 14, 2022
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J.— July 12, 2022-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…
CertaraJuly 12, 2022
Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs
The FDA-ASCO (American Society of Clinical Oncology) workshop on oncology dose optimization (3-5 May 2022)…
CertaraJuly 8, 2022
Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey
Cell therapies aim to treat, prevent, or potentially cure diseases. They are a relatively new…
CertaraJuly 8, 2022
